S100B and early-onset autosomal dominant Alzheimer disease: S100-β protein serves as a biomarker for evaluating the severity of brain injury in various neurological conditions, including traumatic brain injury without multiple trauma (68), acute stroke (69) and Alzheimer’s disease (70) and others.